Pathfinder Cell Therapy (Pathfinder Cell Therapy) Dividends per Share : $0.00 (TTM As of Sep. 2015)

View and export this data going back to . Start your Free Trial

What is Pathfinder Cell Therapy Dividends per Share?

Pathfinder Cell Therapy's dividends per share for the three months ended in Sep. 2015 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Sep. 2015 was $0.00. Its Dividend Payout Ratio for the three months ended in Sep. 2015 was 0.00. As of today, Pathfinder Cell Therapy's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

Pathfinder Cell Therapy Dividends per Share Historical Data

The historical data trend for Pathfinder Cell Therapy's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pathfinder Cell Therapy Dividends per Share Chart

Pathfinder Cell Therapy Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dividends per Share

Get a 7-Day Free Trial

Pathfinder Cell Therapy Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Pathfinder Cell Therapy's Dividends per Share

For the Biotechnology subindustry, Pathfinder Cell Therapy's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pathfinder Cell Therapy's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pathfinder Cell Therapy's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Pathfinder Cell Therapy's Dividend Yield % falls into.

Pathfinder Cell Therapy Dividends per Share Calculation

Dividends paid to per common share.

Pathfinder Cell Therapy (OTCPK:PFND) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Pathfinder Cell Therapy's Dividend Payout Ratio for the quarter that ended in Sep. 2015 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2015 )	/	EPS without NRI (Q: Sep. 2015 )
	=	0	/	-0
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Pathfinder Cell Therapy Dividends per Share Related Terms

Thank you for viewing the detailed overview of Pathfinder Cell Therapy's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pathfinder Cell Therapy Inc (OTCPK:PFND) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

12 Bow Street, Cambridge, MA, USA, 02138

Website

http://www.pathfindercelltherapy.com

Pathfinder Cell Therapy Inc is a regenerative medicine company. It is engaged in developing novel cell-based and related therapies for the treatment of diabetes, renal diseases and medical conditions characterized by organ-specific cell damage. Further, the group has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells ("PCs") themselves being incorporated into the new tissue. Geographically the business activities are functioned through the region of United States.

Executives

John J Alam	director	130 WAVERLY STREET, CAMBRIDGE MA 02139
John L Brooks	director	100 LOWDER BROOK DRIVE SUITE 2500, WESTWOOD MA 02090

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Headlines

No Headlines